Legend Biotech Surges Amid Takeover Speculation

Seeking Alpha01:47

Watching Legend Biotech; Shares Spike Higher As Traders Circulate M&A Blog Comments Suggesting The Company May Be Receiving Activist Interest

Benzinga01:28

RBC Capital Maintains Legend Biotech(LEGN.US) With Buy Rating, Cuts Target Price to $84

Futu NewsJan 7 22:35 · Ratings

BMO Capital Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $90

Futu NewsJan 7 21:35 · Ratings

Promising Growth Trajectory and Market Expansion Justify Buy Rating for Legend Biotech

TipRanksJan 7 20:56 · Ratings

RBC Trims Price Target on Legend Biotech to $84 From $86, Keeps Outperform Rating

MT NewswiresJan 7 20:54 · Ratings